
Spencer Pharmaceutical Inc. SPPH
SPPH
Spencer Pharmaceutical Inc. LGND
Ligand Pharmaceuticals Incorporated ROTH
PharmaRoth Labs, Inc. WPHM
Winston Pharmaceuticals, Inc. DECN
Decision Diagnostics Corp. MEDD
Medical Imaging Corp. ENDV
Endonovo Therapeutics, Inc. HAVLF
HAVN Life Sciences Inc. CHME
China Medicine Corporation GMVDF
G Medical Innovations Holdings Ltd
Spencer Pharmaceutical Inc. LGND
Ligand Pharmaceuticals Incorporated ROTH
PharmaRoth Labs, Inc. WPHM
Winston Pharmaceuticals, Inc. DECN
Decision Diagnostics Corp. MEDD
Medical Imaging Corp. ENDV
Endonovo Therapeutics, Inc. HAVLF
HAVN Life Sciences Inc. CHME
China Medicine Corporation GMVDF
G Medical Innovations Holdings Ltd
Performance
Periode | SPPH | LGND | ROTH | WPHM | DECN | MEDD | ENDV | HAVLF | CHME | GMVDF |
---|---|---|---|---|---|---|---|---|---|---|
6M | 0.00 % | 73.31 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | -66.67 % | -90.00 % | 1 100.00 % | -50.00 % |
YTD | 0.00 % | 67.54 % | 0.00 % | 0.00 % | 9 900.00 % | 0.00 % | -85.71 % | -90.00 % | -60.00 % | -50.00 % |
1Y | 0.00 % | 70.12 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | -88.89 % | 0.00 % | 1 100.00 % | -50.00 % |
3Y | 614.29 % | 102.78 % | 9 900.00 % | -99.67 % | 0.00 % | -66.67 % | -98.70 % | -99.86 % | 500.00 % | -100.00 % |
5Y | 9 900.00 % | 95.36 % | -83.33 % | -99.67 % | -99.95 % | -98.39 % | -99.86 % | -100.00 % | -89.09 % | -100.00 % |
10Y | 9 900.00 % | 94.63 % | -98.46 % | -99.67 % | -99.92 % | -99.78 % | -100.00 % | -100.00 % | -92.00 % | -100.00 % |
Depuis le début | 9 900.00 % | 296.17 % | -99.88 % | -99.67 % | -100.00 % | -99.98 % | -100.00 % | -100.00 % | -99.95 % | -100.00 % |